Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, ...

Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis ...

Exicure, Inc. today announced that GPCR Therapeutics USA, a subsidiary of Exicure Inc., has dosed the 19th patient in its ongoing Phase 2 clinical trial evaluating GPC-100 (burixafor), a small ...

Early infection incidence in patients with multiple myeloma following treatment with cilta-cel infusion highlights the ...

Plasma cell leukemia (PCL) is a rare disease that may present de novoor secondary to plasma cell myeloma. Advanced disease and extramedullary involvement are common clinical features at presentation.

A new study conducted by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National ...

A new study conducted by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has uncovered a key mechanism behind lenalidomide resistance ...

A new study conducted by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National ...

Detailed price information for Telo Genomics Corp (TELO-X) from The Globe and Mail including charting and trades.

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for human ...